No guarantee CETA concessions will bolster pharmaceutical R&D investment in Canada
Final negotiations around Canada-Europe free trade pact focused on intellectual property, but experts say stronger patent protection won’t guarantee more research dollars.
SPONSORED CONTENT
Get Mondays: Environment Newsletter
From climate change to natural resources, dive into environmental legislation, policy, and advocacy.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy











